Marco's Morning Report — Saturday, August 1, 2026

Good morning, Marco. Rule season closed yesterday. CMS dropped the FY 2027 inpatient final rule at 3:20 PM Friday, and buried in the quality section is a new readmission measure built on sepsis — which is to say, on your admissions. The post-acute rules landed the same week, so the whole discharge chain repriced at once. Iran is loud again after the pause. Golf tech had nothing new in 48 hours, and the movie slate is genuinely thin, so I'm not going to invent either.

Section A — Top Stories

FY 2027 inpatient final rule is out — and sepsis readmissions are now a payment measure

CMS issued the FY 2027 IPPS final rule yesterday afternoon: a net 2.3% rate update (3.2% market basket minus a 0.9% productivity cut — a bigger cut than proposed), worth about $2.9 billion more in hospital payments, plus $228 million more in DSH/uncompensated care and $779 million more in new-technology add-ons. The piece that touches your shift: CMS adopted a new measure on readmission following sepsis hospitalization into the Hospital Readmissions Reduction Program, with one extra year before it affects payment. Also finalized: every condition-specific IQR measure now includes Medicare Advantage beneficiaries; three measures removed, eight adopted, three modified; CJR-X goes mandatory nationwide Jan. 1, 2028 (three months later than proposed); and the electronic prior authorization measure becomes an optional bonus in CY 2027, mandatory in CY 2028, now extended to drugs under the medical benefit. AHA's Joanna Hiatt Kim called the update "inadequate" and the productivity cut "extremely high."

Why it matters to you: Sepsis is the most common thing you admit at 2 AM and the most common thing that bounces back in 30 days. Until now, sepsis lived in your world as a bundle-compliance problem (SEP-1) and a mortality index. It's about to become a readmissions penalty, which means the hospital's attention will shift from what happens in the first three hours to what happens in the two weeks after discharge — antibiotic completion, volume status, functional decline, the post-sepsis syndrome nobody codes for. The extra year is your runway. Adding MA beneficiaries to the condition-specific measures also quietly enlarges the denominator on your elderly panel, since a large share of your admits are MA.

Talking point: At the next group meeting, ask who owns post-sepsis follow-up today — hospitalist, PCP, or nobody. That's the answer that determines whether this measure costs the hospital money in FY 2029.

The rest of the discharge chain repriced this week too — SNF, IRF, IPF, LTCH

The post-acute final rules all landed in the same seven-day window. Skilled nursing facilities get 2.4% for FY 2027 (July 29). Inpatient psychiatric facilities get 2.3% (July 29). Inpatient rehab facilities got both a payment update and coverage changes (July 30). Long-term care hospitals get 2.3% (July 31). All effective Oct. 1.

Why it matters to you: Every one of these is a place you send someone at 6 AM when the bed board is full. The IRF coverage changes are the ones worth reading rather than skimming — coverage criteria determine whether the rehab liaison says yes to your deconditioned 84-year-old or whether that patient sits another two days waiting on a SNF bed. Payment updates in the 2.3–2.4% range against real cost growth mean post-acute partners will get more selective about who they accept, not less.

Suggested action: Ask case management to flag any change in IRF acceptance patterns starting in October. If the liaison starts declining patients you'd have placed in July, that's the rule, not the patient.

Iran: the pause is over, and the administration is signaling more

After a brief lull in late July, the U.S. resumed a "heavy wave of strikes" overnight Wednesday, and Trump indicated at a Cabinet meeting that they aren't ending soon — "We'll be hitting them very hard and, you know, at some point, they're going to say, 'We just can't take it anymore.'" The White House confirmed further weekend rounds are on the table. Spillover continues: Kuwait's army destroyed drones that entered its airspace, attributing the incursion to Iranian strikes on installations there. This is now five months into the conflict and roughly six weeks past the collapse of the June ceasefire. Al Jazeera has the fullest running account of the regional dimension.

Why it matters to you: Mostly indirectly, but the indirect channel is real: sustained conflict keeps fuel and shipping costs elevated, which keeps drug and supply-chain pricing elevated, which shows up eventually in the same hospital margin conversation that produced the "inadequate update" line above.

Section B — The Debate

Should health plans be allowed to issue prior-authorization denials generated by AI?

Why it's live right now: Reps. Herb Conaway (D-N.J.) and Gregory Murphy (R-N.C.) — both physicians — introduced the bipartisan Protecting Patients from Automated Denials Act on July 16, and the AMA put its weight behind it in its July 31 advocacy update. Meanwhile CMS is running the opposite experiment: the WISeR model has been using AI-assisted prior authorization inside traditional Medicare since Jan. 1 in six states, and yesterday's IPPS rule made electronic prior authorization a mandatory hospital measure starting CY 2028.

The case for AI in the loop

Prior authorization is slow because it is manual, and manual review is where inconsistency lives — the same request gets different answers depending on who opens the file. Automating the first pass is how you get decisions in hours instead of weeks. Abe Sutton, director of the CMS Innovation Center, has argued that the target is low-value care that hurts patients rather than helps them: "Low-value services, such as those of focus in WISeR, offer patients minimal benefit and, in some cases, can result in physical harm and psychological stress. They also increase patient costs while inflating health care spending." He points out that WISeR contractors are not paid to deny — they're instructed to "get the determination right" — and that decisions come within 72 hours, 48 for expedited cases, with human clinical review layered on top. On the commercial side, AHIP reports that plans have already eliminated 11% of prior authorizations — 6.5 million fewer — and are targeting real-time answers on 80% of electronically submitted approvals by Jan. 1, 2027. That target is unreachable without automation.

The case against AI denials

A model can approve quickly without being trusted to deny. Denial is the decision with clinical consequences, and it should carry a physician's name. That's the premise of the Conaway–Murphy bill, which would bar plans from relying solely on automated tools: any AI-generated denial would require documented review by a qualified physician under the medical director's clinical direction, direct access to that reviewing physician, disclosure that AI was used, ten-year record retention, and reports to HHS every 90 days. The AMA's framing is blunt — "Artificial intelligence is no substitute for a highly trained physician," and MA plans "should not be permitted to empower AI to make prior authorization decisions, especially denials of medically necessary treatment." A 2025 AMA survey found 61% of physicians worry AI will increase denials of care they consider necessary. Critics of WISeR, including members of Congress who wrote to CMS, note that technology partners are compensated in part on the volume of care they deny — an incentive structure the model's defenders have to argue around rather than remove.

Where it might land: The Conaway–Murphy bill has no scheduled markup; the nearer-term forcing function is CMS's own CY 2027/2028 electronic prior authorization timeline, which will make hospitals participants in the automated pipeline whether or not Congress sets rules for the denial end of it.

Section C — On My Radar

Mets are selling, and the deadline is Monday. A.J. Minter went to the Twins for Billy Amick and Bruin Agbayani. Freddy Peralta was scratched from Friday's start with the Mets asking a top-100 prospect plus more; Tampa Bay and Philadelphia are circling. Luis Robert Jr. is drawing interest but the Mets would need to eat salary. Everyone is available except Soto, Lindor, Benge, Ewing, McLean and Scott. Deadline is Monday, Aug. 3 at 6 PM ET.

Cuba's grid had its worst week of the year. The Unión Eléctrica reported a 2,042 MW shortfall Friday, with projections that up to 70–74% of the island would be dark simultaneously at peak demand. ECLAC now projects Cuba's 2026 GDP contraction at −6.5%, the deepest in the region.

Puerto Rico: heat, not storms. Excessive heat risk continues across PR and the USVI with heat indices above 100°F, while the Atlantic stays quiet — no tropical development expected in the next seven days. On the ground, the González administration and LUMA are still trading blame over generation margins, with the governor accusing the operator of manufacturing "chaos and hysteria" over load-shedding warnings.

Cyclospora holding steady. CDC's latest investigation update still shows 1,947 confirmed cases across 9 states, 98 hospitalizations, no deaths, with illness onsets running June 22 through July 20. No new states since Thursday. Traceback still points to Taylor Farms de México iceberg lettuce, recalled July 17.

Golf tech: no new developments in the past 48 hours. The most recent items of substance are still mid-July — the sub-$800 Par Breaker Swing Pulse X10 with dual-camera plus radar, and FlightScope's Mevo Gen2 Range for driving-range installs.

Movies: also thin. Nothing new opened with strong reviews this weekend. The August slate that critics are watching includes Buddy, Ice Cream Man (Eli Roth) and Mutiny; The End of Oak Street (Aug. 14) is currently sitting at 37% on the Tomatometer, so early word is not kind.

Section D — Trends to Watch

Quality measurement is moving downstream from the admission to the recovery. A sepsis readmission measure in HRRP, an Advance Care Planning eCQM in the pipeline, Excess Days in Acute Care for diabetes — CMS is steadily shifting what it counts from "what did you do in the hospital" to "what happened after they left." That's a structural change in what a hospitalist is accountable for, and it arrives without any change in how the day is staffed.

Medicare Advantage is being folded into the denominator. Making every condition-specific IQR measure include MA beneficiaries, and mirroring the change in Value-Based Purchasing, ends the long-standing split where quality was measured on FFS patients while the hospital's actual population skewed MA. Expect measured rates to move — probably not favorably — for reasons that have nothing to do with care changing.

Prior authorization is becoming machine-to-machine on both ends. Plans automate the review; hospitals get a mandatory electronic submission measure in CY 2028, now extended to medical-benefit drugs. Whether a human sits in the middle on the denial side is exactly the question Section B is about, and it's being decided after the plumbing is already built.

Mandatory bundles keep expanding into hospital resistance. CJR-X goes nationwide and mandatory in 2028 over AHA's objection that low-volume hospitals lack the case counts to make care redesign meaningful. TEAM keeps getting refined rather than reconsidered. The direction of travel is settled; the fight is now about thresholds and pricing.

Section E — Ideas & Opportunities

Own the post-sepsis handoff before someone assigns it to you. There's a year of runway before the new HRRP measure bites. A one-page post-sepsis discharge element — antibiotic completion date, follow-up within 7 days, explicit functional-status note, family-facing "what post-sepsis fatigue looks like" paragraph — is the kind of thing that's cheap to build now and expensive to retrofit in FY 2029.

Bring the CY 2027/2028 electronic prior authorization timeline to whoever runs your rev cycle and IT. Optional bonus next year, mandatory the year after, and now covering drugs under the medical benefit. Better to be the physician in the room when the workflow gets designed than the one who inherits it.

Watch what the Mets get back, not what they give up. If Peralta actually returns a top-100 prospect, this deadline is a rebuild with a plan. If he goes for organizational filler, it's a salary dump wearing a rebuild's clothes. Monday at 6 tells you which.